Apart from PC, other malignant lesions presenting with increased PSMA expression have been reported for glioblastoma, hepatocellular carcinoma, lung cancer, renal cell carcinoma and thyroid cancer [38–42]. This evidence concerns the gene FOLH1 and lung carcinoma.